Is Indraprastha Medical Corporation the Best Stock in Its Sector? A Look at the Numbers
- September 29, 2026
- Posted by: Neeraj Pandey
- Category: Market
Indraprastha Medical Corporation CMP Rs 355 (29 Sep 2026). Market cap Rs 3,297 Cr. ROE 24.80%. P/E 17.53x versus Industry P/E 92.35x.
Quick Answer
Indraprastha Medical Corporation is one of the names investors compare when screening the Healthcare sector, built on a 24.80% return on equity and a P/E of 17.53x against an Industry P/E of 92.35x. Whether Indraprastha Medical Corporation is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.
Is Indraprastha Medical Corporation the best stock in its sector? The stock trades on the NSE at Rs 355 as of 29 September 2026, within its 52-week range of Rs 342.00 to Rs 640.85. Indraprastha Medical Corporation Ltd operates the Indraprastha Apollo Hospital in Delhi.
Indraprastha Medical Corporation sits in the Healthcare sector, and its 24.80% ROE and 17.53x P/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P/E benchmark.
Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers
Click Here – Get Free Investment Predictions
About Indraprastha Medical Corporation
Indraprastha Medical Corporation Ltd operates the Indraprastha Apollo Hospital in Delhi. The stock is trading close to its 52-week low, about 44 percent below its high. At a market capitalisation of Rs 3,297 Cr, it is tracked as part of the Healthcare sector on Univest.
Is Indraprastha Medical Corporation the Best Stock in Its Sector?
Indraprastha Medical Corporation makes its case as the best stock in its sector primarily on return on equity and balance sheet strength, combining a 24.80% ROE with a 17.53x P/E against the sector’s 92.35x Industry P/E. Indraprastha Medical Corporation’s 17.53x P/E is far below the 92.35x Industry P/E with a 24.80% ROE, but that benchmark is skewed by larger chains, and the stock has fallen about 44 percent from its 52-week high.
| Metric | Indraprastha Medical Corporation |
|---|---|
| CMP (NSE) | Rs 355.05 |
| 52-Week High / Low | Rs 640.85 / Rs 342.00 |
| Market Cap | Rs 3,297 Cr |
| P/E (TTM) vs Industry P/E | 17.53x vs 92.35x |
| P/B | 4.45 |
| ROE | 24.80% |
| EPS (TTM) | Rs 20.51 |
| Dividend Yield | 1.11% |
| Debt to Equity | 0.05 |
Compare Indraprastha Medical Corporation Against Other Healthcare Sector Stocks
How Indraprastha Medical Corporation Compares Against Its Healthcare Sector Peers
The table below sets Indraprastha Medical Corporation against 2 other Healthcare sector names, using the same live data source for every company. A peer average row is included for P/E, ROE and debt to equity, calculated across the 2 peer companies.
| Company | Market Cap (Rs Cr) | P/E | ROE | Debt to Equity |
|---|---|---|---|---|
| Indraprastha Medical Corporation | 3,297 | 17.53 | 24.80% | 0.05 |
| GPT Healthcare | 1,321 | 27.95 | 15.67% | 0.34 |
| Dr. Agarwal’s Health Care | 15,908 | 85.92 | 6.58% | 0.53 |
| Peer average (2 companies) | – | 56.94 | 11.12% | 0.44 |
Against this peer set, Indraprastha Medical Corporation’s 24.80% ROE is above the 11.12% peer average, and its P/E of 17.53x runs below the peer average of 56.94x. Indraprastha Medical Corporation’s 17.53x P/E is far below the 92.35x Industry P/E with a 24.80% ROE, but that benchmark is skewed by larger chains, and the stock has fallen about 44 percent from its 52-week high.
What Makes Indraprastha Medical Corporation Worth Watching in Healthcare
- Strong ROE, near debt free: A 24.80% ROE alongside a debt to equity ratio of 0.05 reflects an efficient, well-capitalised hospital operator.
- Well below Industry P/E: A 17.53x P/E against a 92.35x Industry P/E is a wide discount, though that benchmark is pulled up by larger hospital chains.
- Single flagship hospital: Earnings depend heavily on one large Delhi hospital, which concentrates both the strength and the risk.
Indraprastha Medical Corporation Valuation: Is It Justified?
Indraprastha Medical Corporation’s 17.53x P/E is far below the 92.35x Industry P/E with a 24.80% ROE, but that benchmark is skewed by larger chains, and the stock has fallen about 44 percent from its 52-week high. As with any single stock, investors should weigh this against their own valuation discipline and risk appetite rather than the sector label alone.
Also read – Is Indegene the Best Stock in Its Sector? A Look at the Numbers
Download the Univest iOS App or Univest Android App to track Indraprastha Medical Corporation and other Healthcare sector stocks.
How to Track Indraprastha Medical Corporation Before You Invest
Before deciding whether Indraprastha Medical Corporation deserves its label as the best stock in its sector for your own portfolio, compare it directly against Healthcare sector peers using the steps below.
- Open the Univest Screener and search for Indraprastha Medical Corporation to view live price, valuation ratios, and peer comparisons within the Healthcare sector.
- Compare its P/E, P/B, and ROE against other Healthcare sector stocks before deciding if the current valuation fits your strategy.
- Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.
- Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.
Conclusion
Indraprastha Medical Corporation earns a place in the best stock in its sector conversation on the strength of a 24.80% ROE and a P/E of 17.53x against a 92.35x Industry P/E, with named peer comparisons in this article backing up that picture. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Is Indraprastha Medical Corporation the best stock in its sector?
Ans. Indraprastha Medical Corporation has a 24.80% ROE and trades at 17.53x P/E against a 92.35x Industry P/E, and compares above the peer average ROE of 11.12% in this article’s named comparison, so the answer depends on what an investor is prioritising.
What is the current share price of Indraprastha Medical Corporation?
Ans. Indraprastha Medical Corporation was trading at Rs 355.05 on the NSE as of 29 September 2026, within its 52-week range of Rs 342.00 to Rs 640.85.
What sector does Indraprastha Medical Corporation belong to?
Ans. Indraprastha Medical Corporation is classified under the Healthcare sector on Univest.
How does Indraprastha Medical Corporation compare to its sector peers on P/E?
Ans. Indraprastha Medical Corporation’s P/E of 17.53x is below the 56.94x average of the 2 named peers compared in this article.
What is Indraprastha Medical Corporation’s return on equity?
Ans. Indraprastha Medical Corporation reported a return on equity of 24.80%, which is above the 11.12% average of its named peers in this comparison.
Should I invest in Indraprastha Medical Corporation based on its sector position?
Ans. Indraprastha Medical Corporation’s sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.
